Global Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market Research Report – Segmentation By Application (Neurotransmitter Receptors, Neuroinflammation, Brain Tumors, Alzheimer's disease, Parkinson's disease, Schizophrenia, Bipolar Disorder, Others); By product type traditional PET system, helium-free PET system, PET-CT system, PET-MRI system, or PET insert); By end-use (Hospitals, Clinics, Diagnostic Centers, Research Institutes, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15344
Format:
Region: Global
Chapter 1. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market - By Application
6.1 Neurotransmitter receptors
6.2. Neuroinflammation
6.3. Brain tumors
6.4. Alzheimer's disease
6.5. Parkinson's disease
6.6. Schizophrenia
6.7. Bipolar disorder
6.8. Others
Chapter 7. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market - By Product Type
7.1. Traditional PET system
7.2. Helium-free PET system
7.3. PET-CT system
7.4. PET-MRI system or PET insert
Chapter 8. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market - By End-Use
8.1. Hospitals
8.2. Clinics
8.3. Diagnostic centers
8.4. Research institutes
8.5. Others
Chapter 9. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market – By Region
9.1. North America
9.2. Europe
9.3.The Asia Pacific
9.4.Latin America
9.5. Middle-East and Africa
Chapter 10. Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1. Siemens Healthineers AG
10.2. Koninklijke Philips N.V.
10.3. GE Healthcare
10.4. Bruker
10.5. Mediso Ltd
10.6. MR Solutions
10.7. Cubresa Inc
10.8. Aspect Imaging
10.9. Agfa Healthcare
10.10. Neusoft Medical Systems
Download Sample
Choose License Type
2500
4250
5250
6900
Frequently Asked Questions
Positron-emitting radionuclides must be able to be precisely detected and imaged for PET to work. Short-lived radionuclides are intravenously injected during this procedure, and the patient is subsequently imaged using a specialized detection system.
The Global Functional Brain Imaging by Positron Emission Tomography (PET) Systems Market was estimated to be worth USD 4.1 Billion in 2022 and is projected to reach a value of USD 6.68 Billion by 2030, growing at a CAGR of 6.3% during the forecast period 2023-2030.
The technological advancements in PET imaging and the use of positron emission tomography (PET) scanners are drivers of the Functional Brain Imaging by Positron Emission Tomography (PET) Systems market.
In the market for PET systems, the technological challenges of combining PET with other functional imaging modalities, such as MRI or ultrasound, might be difficult.
Some of the major players are Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Bruker, Mediso Ltd, MR Solutions, Cubresa Inc, Aspect Imaging, Agfa Healthcare, Neusoft Medical Systems
